Latest Takeda Pharmaceutical Company Stories
ZURICH, October 27, 2014 /PRNewswire/ -- - Cross reference: Picture is available at epa european pressphoto agency (http://www.epa.eu) and http://www.presseportal.de/pm/111920
RnRMarketResearch.com adds “Hypertension – Pipeline Review, H2 2014” to its store.
Another Actos Lawsuit Purports Patient Develop Bladder Cancer After Taking The Type Two Diabetes Medication Columbus, OH (PRWEB) October 18, 2014 Wright
DALLAS, October 18, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Autism - Pipeline Review, H2 2014" and "Endometriosis - Pipeline Review, H2 2014" market research reports
RnRMarketResearch.com adds “Osteoporosis & Osteoarthritis – Pipeline Review, H2 2014” to its store.
The Philadelphia jury awarded the man $2 million: Actos was deemed a contributing factor to the man’s bladder cancer, Takeda was found to have not warned physicians concerning the drug’s cancer
Pegasus Legal Funding LLC Can Provide Financial Assistance to Those Adversely Affected NEW YORK, Oct.
The Actos Lawsuit Purports Takeda Pharmceuticals Knew Long-Term Use Of The Medication Could Potentially Lead To Bladder Cancer. Columbus, OH (PRWEB) October
Expresses Continued Confidence in ACTOS DEERFIELD, Ill., Oct. 3, 2014 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc.